Tentative Provisions for the Administration of the Designation of a Domestic Responsible Person by Foreign Marketing Authorization Holders

境外药品上市许可持有人指定境内责任人管理暂行规定

Foreign marketing authorization holders are required to designate a domestic responsible person in China ; Clp Reference: 2600/24.11.13 ; Issued: 2024-11-13 ; Effective: 2025-07-01

(Issued by the National Medical Products Administration on November 13, 2024 and effective as of July 1, 2025.)

(国家药品监督管理局于二零二四年十一月十三日发布，自二零二五年七月一日起施行。)

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]